Rubraca Drug Interactions
Currently displaying 115 drugs known to have a major interaction with Rubraca (rucaparib).
- 115 major drug interactions
- 585 moderate drug interactions
- 11 minor drug interactions
Major interactions with Rubraca (rucaparib)
Note: Showing generic names only.
A
B
C
- cabozantinib
- ceritinib
- certolizumab
- chikungunya vaccine, live (cvx 317)
- chloramphenicol
- chloroquine
- cholera vaccine, live
- cisapride
- citalopram
- cladribine
- clozapine
- crizotinib
D
- deferiprone
- dengue vaccine
- deucravacitinib
- disopyramide
- dofetilide
- dolasetron
- dronedarone
- droperidol
E
F
G
H
I
- ibutilide
- iloperidone
- infliximab
- influenza virus vaccine, h1n1, live
- influenza virus vaccine, live
- ivabradine
- ivosidenib
L
M
- mavacamten
- measles virus vaccine
- mesoridazine
- methadone
- mifepristone
- mobocertinib
- moxifloxacin
- mumps virus vaccine
N
O
P
- pacritinib
- panobinostat
- papaverine
- pasireotide
- pexidartinib
- pimozide
- pirfenidone
- poliovirus vaccine, live, trivalent
- ponesimod
- posaconazole
- procainamide
Q
R
S
- sacituzumab govitecan
- samarium sm 153 lexidronam
- saquinavir
- siponimod
- sirolimus protein-bound
- smallpox vaccine
- sotalol
- sparfloxacin
- strontium-89 chloride
T
- talimogene laherparepvec
- teriflunomide
- thioridazine
- tizanidine
- tofacitinib
- toremifene
- typhoid vaccine, live
U
V
Y
Z
Rubraca alcohol/food interactions
There is 1 alcohol/food interaction with Rubraca (rucaparib).
Rubraca disease interactions
There are 3 disease interactions with Rubraca (rucaparib) which include:
More about Rubraca (rucaparib)
- Rubraca consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: PARP inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.